Ellington Financial Inc. filings document formal disclosures for a specialty finance company with an investment portfolio segment and a Longbridge segment focused on reverse mortgage loan origination and servicing. Form 8-K reports cover quarterly operating results, Regulation FD book value updates, common stock dividends, and dividends on Series B, Series C, and Series D preferred stock.
Proxy materials describe board and shareholder-voting matters, executive compensation, equity awards, and pay-versus-performance disclosures. The filings also identify the company's reported common and preferred equity classes and provide recurring records of financial condition, portfolio valuation disclosures, capital-return actions, governance, and risk-related forward-looking statements.
Ellington Financial Inc. furnished a Current Report on Form 8-K to provide a press release announcing its estimated book value per share as of July 31, 2025. The press release dated August 27, 2025 is attached as Exhibit 99.1 and is being furnished under Item 7.01 for Regulation FD purposes. The filing clarifies that the disclosed material is being furnished (not "filed") and therefore is not subject to the liabilities of Section 18 of the Exchange Act and is not incorporated by reference into other filings except by specific reference. The exhibit list also includes the Inline XBRL cover page file as itemized in Item 9.01.
Ellington Financial Inc. reported consolidated assets of $17,071,895 (in thousands) and total liabilities of $15,382,385 as of June 30, 2025, up from $16,317,028 and $14,726,206 at December 31, 2024, respectively. The Company held $211,013 of cash and $19,617 of restricted cash (in thousands) and recorded $14,668,365 in loans, at fair value. Investments in unconsolidated entities increased to $307,722 from $220,078.
For the three months ended June 30, 2025 the Company reported net interest income of $43,343 (in thousands) and total other income (loss) of $49,199. Total expenses were $57,066, producing net income of $51,073 and net income attributable to common stockholders of $42,923. Basic and diluted EPS for the quarter were $0.45 (compared with $0.62 a year earlier). For the six months, net income was $90,397 and EPS was $0.80.
Key balance sheet and financing items include HMBS-related obligations of $9,814,811, repurchase agreements and reverse repurchase activity supporting portfolio financings, and total equity of $1,689,510. The registrant reported 99,893,894 common shares outstanding as of August 8, 2025. (All dollar amounts presented in the filings are expressed in thousands.)